Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Sell
40
CRARY Quote, Financials, Valuation and Earnings
Last price:
$9.11
Seasonality move
:
1.75%
Day range:
$9.00 - $9.12
52-week range:
$6.44 - $10.20
Dividend yield:
6.6%
P/E ratio:
8.37x
P/S ratio:
2.06x
P/B ratio:
0.66x
Volume:
162.7K
Avg. volume:
207.2K
1-year change:
14.02%
Market cap:
$55.1B
Revenue:
$27.4B
EPS (TTM):
$1.09
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $20.6B | $25.3B | $21.8B | $25.4B | $27.4B | |
| Revenue Growth (YoY) | -3.9% | 23.05% | -14% | 16.62% | 7.96% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -$842.6M | -$888.8M | -$900.5M | |
| Other Inc / (Exp) | -$107.4M | $5.5B | -$1.1B | -$937.5M | $234.9M | |
| Operating Expenses | $14.7B | $16.3B | $14B | $15.3B | $16.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $5.2B | $9.6B | $8.3B | $10.3B | $11.5B | |
| Earnings of Discontinued Ops. | -$252.4M | $5.9M | $127.6M | -$3.2M | -- | |
| Income Tax Expense | $1.3B | $1.5B | $1.9B | $2.4B | $2.7B | |
| Net Income to Company | $5.2B | $9.6B | $8.3B | $10.3B | $11.5B | |
| Minority Interest in Earnings | -$623.5M | -$1.2B | -$928M | -$1.1B | -$1.2B | |
| Net Income to Common Excl Extra Items | $3.1B | $6.9B | $5.6B | $6.9B | $7.7B | |
| Basic EPS (Cont. Ops) | $0.46 | $1.09 | $0.86 | $1.05 | $1.14 | |
| Diluted EPS (Cont. Ops) | $0.46 | $1.09 | $0.86 | $1.05 | $1.14 | |
| Weighted Average Basic Share | $5.8B | $6B | $6B | $6.1B | $6B | |
| Weighted Average Diluted Share | $5.8B | $6B | $6B | $6.1B | $6B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $18.6B | $23.4B | $26.2B | $58.9B | $64.7B | |
| Revenue (Reported) | $20.6B | $25.3B | $21.8B | $25.4B | $27.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $18.6B | $23.4B | $26.2B | $58.9B | $64.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.6B | $6.3B | $6.6B | $7.4B | $7.6B | |
| Revenue Growth (YoY) | 15.3% | -5.22% | 4.8% | 12.28% | 3.38% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $4.3B | $4.2B | $4.1B | $4B | $4.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2B | $1.3B | $2.1B | $3B | $3.1B | |
| Earnings of Discontinued Ops. | -$7.2M | $1.1M | $2.1M | -- | -- | |
| Income Tax Expense | $455.5M | $450M | $559.6M | $662.6M | $870.2M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$232.6M | -$234.5M | -$268.5M | -$281.3M | -$262M | |
| Net Income to Common Excl Extra Items | $1.3B | $640.7M | $1.3B | $2.1B | $1.9B | |
| Basic EPS (Cont. Ops) | $0.19 | $0.08 | $0.19 | $0.27 | $0.29 | |
| Diluted EPS (Cont. Ops) | $0.19 | $0.08 | $0.19 | $0.27 | $0.29 | |
| Weighted Average Basic Share | $5.8B | $6B | $6B | $6B | $6.1B | |
| Weighted Average Diluted Share | $5.8B | $6B | $6B | $6B | $6.1B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2B | $1.3B | $2.1B | $3B | $3.1B | |
| Revenue (Reported) | $6.6B | $6.3B | $6.6B | $7.4B | $7.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2B | $1.3B | $2.1B | $3B | $3.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $19.6B | $24.5B | $23.3B | $25.2B | $26.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $15B | $16.2B | $14.7B | $15.2B | $16.3B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $6B | $9B | $9.4B | $11.2B | $11.5B | |
| Earnings of Discontinued Ops. | -$269M | $14.3M | $119.7M | -$4.2M | -- | |
| Income Tax Expense | $1.5B | $1.5B | $2B | $2.5B | $2.9B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$675.5M | -$1.2B | -$959.9M | -$1.1B | -$1.1B | |
| Net Income to Common Excl Extra Items | $3.6B | $6.3B | $6.6B | $7.6B | $7.5B | |
| Basic EPS (Cont. Ops) | $0.56 | $0.98 | $0.97 | $1.13 | $1.16 | |
| Diluted EPS (Cont. Ops) | $0.56 | $0.97 | $0.97 | $1.13 | $1.09 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $6B | $9B | $9.4B | $11.2B | $11.5B | |
| Revenue (Reported) | $19.6B | $24.5B | $23.3B | $25.2B | $26.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $6B | $9B | $9.4B | $11.2B | $11.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.6B | $6.3B | $6.6B | $7.4B | $7.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $4.3B | $4.2B | $4.1B | $4B | $4.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2B | $1.3B | $2.1B | $3B | $3.1B | |
| Earnings of Discontinued Ops. | -$7.2M | $1.1M | $2.1M | -- | -- | |
| Income Tax Expense | $455.5M | $450M | $559.6M | $662.6M | $870.2M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$232.6M | -$234.5M | -$268.5M | -$281.3M | -$262M | |
| Net Income to Common Excl Extra Items | $1.3B | $640.7M | $1.3B | $2.1B | $1.9B | |
| Basic EPS (Cont. Ops) | $0.19 | $0.08 | $0.19 | $0.27 | $0.29 | |
| Diluted EPS (Cont. Ops) | $0.19 | $0.08 | $0.19 | $0.27 | $0.29 | |
| Weighted Average Basic Share | $5.8B | $6B | $6B | $6B | $6.1B | |
| Weighted Average Diluted Share | $5.8B | $6B | $6B | $6B | $6.1B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2B | $1.3B | $2.1B | $3B | $3.1B | |
| Revenue (Reported) | $6.6B | $6.3B | $6.6B | $7.4B | $7.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2B | $1.3B | $2.1B | $3B | $3.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $691.1B | $725.6B | $702.3B | $662.1B | $605.1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $674M | $995.2M | $1.4B | $1.6B | $1.6B | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.1T | $1.1T | $1.1T | $1.1T | $1.1T | |
| Property Plant And Equipment | $7.1B | $6.9B | $6.5B | $9.5B | $10.1B | |
| Long-Term Investments | $860B | $771.9B | $702.6B | $762.8B | $813.3B | |
| Goodwill | $18B | $17.7B | $16.8B | $17.6B | $16.9B | |
| Other Intangibles | $3.9B | $3.7B | $3.3B | $3.5B | $3.6B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $2.4T | $2.3T | $2.3T | $2.4T | $2.4T | |
| Accounts Payable | -- | $42.2B | $38.5B | $44.1B | $37.6B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $47.9B | $43.7B | $40.1B | $46.4B | $39.7B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.3T | $2.3T | $2.2T | $2.3T | $2.3T | |
| Common Stock | $34.8B | $32.3B | $31.7B | $34.2B | $32.2B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $80.2B | $77.2B | $71.3B | $78.6B | $77.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $10.2B | $9.8B | $9.6B | $9.8B | $8.9B | |
| Total Equity | $90.4B | $87.1B | $80.9B | $88.3B | $86.7B | |
| Total Liabilities and Equity | $2.4T | $2.3T | $2.3T | $2.4T | $2.4T | |
| Cash and Short Terms | $691.1B | $725.6B | $702.3B | $662.1B | $605.1B | |
| Total Debt | $231.7B | $225.7B | $257.3B | $309.8B | $328.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $269.2B | $280.6B | -- | $191.6B | $177.8B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $312.5B | $303.1B | -- | $213.9B | $199B | |
| Property Plant And Equipment | $12.3B | $6.6B | -- | $9.4B | $10.6B | |
| Long-Term Investments | $1T | $895.5B | -- | $914B | $988.2B | |
| Goodwill | $17.7B | $17.4B | -- | $17.2B | $17.5B | |
| Other Intangibles | $4B | $3.6B | -- | $3.3B | $3.7B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $2.7T | $2.4T | -- | $2.4T | $2.5T | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.8B | $2.9B | -- | $3.1B | $3.6B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.5T | $2.3T | -- | $2.3T | $2.4T | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $8.3B | $9.8B | -- | $9.8B | $10.1B | |
| Total Equity | $149.9B | $85.4B | -- | $88B | $93.8B | |
| Total Liabilities and Equity | $2.7T | $2.4T | -- | $2.4T | $2.5T | |
| Cash and Short Terms | $269.2B | $280.6B | -- | $191.6B | $177.8B | |
| Total Debt | $234.7B | $223B | -- | $327.1B | $344.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $5.2B | $9.6B | $8.3B | $10.3B | $11.5B | |
| Depreciation & Amoritzation | $1.3B | $1.4B | $1.2B | $1.2B | $1.3B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $65.4B | $12.9B | $1.5B | -$39.5B | -$17.2B | |
| Capital Expenditures | $854.2M | $1B | $1.1B | $958.1M | $1.2B | |
| Cash Acquisitions | -$2.8B | $163.3M | -$3.8B | $11.6B | -$770.6M | |
| Cash From Investing | -$3.7B | -$991.5M | -$5.3B | $10.7B | -$1.9B | |
| Dividends Paid (Ex Special Dividend) | -- | -$3.6B | -$3.4B | -$3.7B | -$5.6B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$142.8M | -$3.5M | $4B | $21.7B | $15.8B | |
| Cash From Financing | $8.8B | -$2B | $630.6M | $17.9B | $10.2B | |
| Beginning Cash (CF) | $103.7B | $178.9B | $168.4B | $168.3B | $154.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $70.5B | $9.9B | -$3.1B | -$10.9B | -$8.9B | |
| Ending Cash (CF) | $172.7B | $189B | $163.9B | $154.4B | $144.1B | |
| Levered Free Cash Flow | $64.6B | $11.9B | $444M | -$40.5B | -$18.4B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.5B | $5.2B | $3.8B | $5.4B | $6B | |
| Depreciation & Amoritzation | $587M | $667.7M | $572M | $612.8M | $618.1M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $43.3B | $11.4B | $18.9B | -$43.8B | -$11.3B | |
| Capital Expenditures | $334.8M | $492.9M | $531.5M | $434M | $480.2M | |
| Cash Acquisitions | -$963.7M | $2.2B | -$1.4B | $877.8M | $260.6M | |
| Cash From Investing | -$1.3B | $1.7B | -$2.2B | $444.9M | -$219.7M | |
| Dividends Paid (Ex Special Dividend) | -$365.6M | -$2.7B | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $3.3M | -$120.5M | $1.3B | $12.4B | $20.3B | |
| Cash From Financing | $6.1B | -$1B | -$1.8B | $9.5B | $15.5B | |
| Beginning Cash (CF) | $100B | $182.2B | $170.1B | $169.5B | $153.5B | |
| Foreign Exchange Rate Adjustment | -$772M | -$631.5M | -$1.9B | -$4.3B | -$4.4B | |
| Additions / Reductions | $48.1B | $12.1B | $14.9B | -$33.8B | $4B | |
| Ending Cash (CF) | $147.3B | $193.7B | $183.1B | $131.3B | $153.2B | |
| Levered Free Cash Flow | $43B | $10.9B | $18.4B | -$44.2B | -$11.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | $334.8M | $492.9M | $531.5M | $434M | $480.2M | |
| Cash Acquisitions | -$963.7M | $2.2B | -$1.4B | $877.8M | $260.6M | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$365.6M | -$2.7B | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $5.2B | $3.8B | $5.4B | $6B | -- | |
| Depreciation & Amoritzation | $667.7M | $572M | $612.8M | $618.1M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $11.4B | $18.9B | -$43.8B | -$11.3B | -- | |
| Capital Expenditures | $492.9M | $531.5M | $434M | $480.2M | -- | |
| Cash Acquisitions | $2.2B | -$1.4B | $877.8M | $260.6M | -- | |
| Cash From Investing | $1.7B | -$2.2B | $444.9M | -$219.7M | -- | |
| Dividends Paid (Ex Special Dividend) | -$2.7B | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$120.5M | $1.3B | $12.4B | $20.3B | -- | |
| Cash From Financing | -$1B | -$1.8B | $9.5B | $15.5B | -- | |
| Beginning Cash (CF) | $182.2B | $170.1B | $169.5B | $153.5B | -- | |
| Foreign Exchange Rate Adjustment | -$631.5M | -$1.9B | -$4.3B | -$4.4B | -- | |
| Additions / Reductions | $12.1B | $14.9B | -$33.8B | $4B | -- | |
| Ending Cash (CF) | $193.7B | $183.1B | $131.3B | $153.2B | -- | |
| Levered Free Cash Flow | $10.9B | $18.4B | -$44.2B | -$11.8B | -- | |
Get CRARY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CRARY
Sector
P/E ratio
8.37x
11.67x
PEG ratio
8.01x
0.39x
P/B ratio
0.66x
1.05x
Price / LTM sales
2.06x
2.53x
Growth Metrics
CRARY
Sector
Revenue growth
3.38%
5.04%
Earnings growth
8.5%
2.87%
Revenue (5-year growth)
5.07%
5.18%
Earnings forecast
--
$0.56
Profitability
CRARY
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
1.8%
5.3%
Return on assets
0.31%
0.97%
Return on equity
8.52%
9.25%
Earnings Date
Last Earnings Date
Apr
30
Next Earnings Date
Jul
31
Estimated Next Earnings Date
Jul
30
Balance Sheet
CRARY
Sector
Total cash
$177.8B
$470.2M
Short term investments
--
$233.7M
Total assets
$2.4T
$4B
Long term debt
$344.1B
$296.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
